# Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection

> **NCT02976259** · PHASE3 · COMPLETED · sponsor: **Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba** · enrollment: 20 (actual)

## Conditions studied

- HIV Infection Primary

## Interventions

- **DRUG:** Dolutegravir

## Key facts

- **NCT ID:** NCT02976259
- **Lead sponsor:** Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976259, "Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02976259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*